Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastric/Gastroesophageal Junction Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07552402
What this trial is testing

Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer

Who this might be right for
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Harbin Medical University 150
Testing effectiveness (Phase 2)Ended earlyNCT03707028
What this trial is testing

Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Elevar Therapeutics 12
Large-scale testing (Phase 3)UnknownNCT02409199
What this trial is testing

Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Carcinoma
Shanghai Zhongshan Hospital 66
Early research (Phase 1)Study completedNCT04086758
What this trial is testing

A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma China, Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06157892
What this trial is testing

Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

Who this might be right for
Breast NeoplasmsGastroesophageal Junction AdenocarcinomaHER2 Low Breast Neoplasms+7 more
Seagen, a wholly owned subsidiary of Pfizer 54
Large-scale testing (Phase 3)Not Yet RecruitingNCT07068516
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

Who this might be right for
Gastric Cancer Stage
Xiangdong Cheng 470
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07716111
What this trial is testing

Neoadjuvant SHR-A1811 and SHR-A1701 ± Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 24
Testing effectiveness (Phase 2)Study completedNCT03861793
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)

Who this might be right for
Advanced Solid Tumors
Mural Oncology, Inc 116
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)UnknownNCT05024812
What this trial is testing

Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Metastatic Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 64
Early research (Phase 1)Looking for participantsNCT06610799
What this trial is testing

Study of IBI363 in Patients with Advanced First-line Gastric Cancer

Who this might be right for
IBI363 + Chemotherapy
Xiangdong Cheng 40
Large-scale testing (Phase 3)Study completedNCT05052801
What this trial is testing

Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Amgen 547
Testing effectiveness (Phase 2)Looking for participantsNCT06510010
What this trial is testing

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Who this might be right for
Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University 198
Testing effectiveness (Phase 2)Looking for participantsNCT04908566
What this trial is testing

Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced Gastric Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT05329766
What this trial is testing

A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies

Who this might be right for
Gastrointestinal Tract Malignancies
Arcus Biosciences, Inc. 332
Not applicableNot Yet RecruitingNCT07674342
What this trial is testing

Neoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma

Who this might be right for
Locally Advanced Proximal Gastric or Gastroesophageal Junction Adenocarcinoma
Tongji Hospital 146
Testing effectiveness (Phase 2)Looking for participantsNCT07464756
What this trial is testing

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06155383
What this trial is testing

Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
RemeGen Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT01388790
What this trial is testing

Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer

Who this might be right for
Gastric Cancer
Merck KGaA, Darmstadt, Germany 40
Testing effectiveness (Phase 2)WithdrawnNCT02344810
What this trial is testing

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
Eastern Cooperative Oncology Group
Next Page